Nick Zimmermann
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus.
Journal: International journal of dermatology
Published: May 07, 2025
Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine.
Journal: Scientific reports
Published: May 21, 2024
Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients.
Journal: Frontiers in immunology
Published: November 10, 2022
Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells.
Journal: Frontiers in immunology
Published: April 09, 2022
A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients.
Journal: Frontiers in immunology
Published: March 21, 2022
Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic.
Journal: Dermatopathology (Basel, Switzerland)
Published: October 13, 2020
Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency.
Journal: The Journal of investigative dermatology
Published: September 10, 2020
SMARCAD1 Haploinsufficiency Underlies Huriez Syndrome and Associated Skin Cancer Susceptibility.
Journal: The Journal of investigative dermatology
Published: June 16, 2017
Off‑target effect of imatinib and nilotinib on human vitamin D3 metabolism.
Journal: Molecular medicine reports
Published: June 14, 2017
Deregulated type I IFN response in TREX1-associated familial chilblain lupus.
Journal: The Journal of investigative dermatology
Published: November 26, 2013
Last Updated: 09/26/2026